Arch Therapeutics to Provide Corporate Updates at Upcoming Industry and Investment Conferences
Sep 20, 2017 11:55 am UTC| Business
FRAMINGHAM, Mass., Sept. 20, 2017 -- Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will present...
Endeavour Launches Construction of Ity CIL Project Based on Optimization Study
Sep 20, 2017 11:47 am UTC| Business
View Funding Sources ...
Ascendant Resources Announces August 2017 Operational Results
Sep 20, 2017 11:30 am UTC| Business
Second consecutive month of positive adjusted EBITDATonnes milled increased to 1,903 tpd, up 9.8% from Q2 average and 53% from January 2017Fleet renewal in-process with new equipment ordered TORONTO, Sept. 20, 2017 --...
Sep 20, 2017 11:30 am UTC| Business
- Actinium is now a member of the ASBMT™ Corporate Council - Two day event focused on facilitating dialogue aimed at advancing the field of bone marrow transplantation and cellular therapy NEW YORK, Sept. 20, 2017 --...
Merus’ Intellectual Property Portfolio Expands with Two New Patents For its Biclonics® Technology
Sep 20, 2017 11:30 am UTC| Business
UTRECHT, The Netherlands, Sept. 20, 2017 -- Merus (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing therapeutics with the goal of treating and curing serious illnesses, announced today that it has added...
Sep 20, 2017 11:30 am UTC| Business
Delivery Trust™ Email Encryption Service Provides Insurance Providers the Most Secure and Cost-Effective Way to Ensure Secure Communication Delivery Trust™ Email Encryption Service Provides Businesses the Most Effective...
OpGen to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 20, 2017 11:30 am UTC| Business
GAITHERSBURG, Md., Sept. 20, 2017 -- OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2017...